1. Home
  2. OPRX vs RPID Comparison

OPRX vs RPID Comparison

Compare OPRX & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OptimizeRx Corporation

OPRX

OptimizeRx Corporation

HOLD

Current Price

$6.38

Market Cap

117.1M

ML Signal

HOLD

Logo Rapid Micro Biosystems Inc.

RPID

Rapid Micro Biosystems Inc.

HOLD

Current Price

$2.01

Market Cap

102.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OPRX
RPID
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.1M
102.6M
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
OPRX
RPID
Price
$6.38
$2.01
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
1
Target Price
$16.67
$8.00
AVG Volume (30 Days)
301.7K
240.0K
Earning Date
05-12-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
124.55
2.78
EPS
N/A
N/A
Revenue
$109,429,000.00
$33,587,000.00
Revenue This Year
$3.88
$19.12
Revenue Next Year
$8.34
$18.42
P/E Ratio
N/A
N/A
Revenue Growth
18.78
19.74
52 Week Low
$4.54
$1.66
52 Week High
$22.25
$4.94

Technical Indicators

Market Signals
Indicator
OPRX
RPID
Relative Strength Index (RSI) 56.91 51.88
Support Level $6.03 $1.98
Resistance Level $6.93 $2.17
Average True Range (ATR) 0.24 0.15
MACD -0.04 0.01
Stochastic Oscillator 48.47 50.00

Price Performance

Historical Comparison
OPRX
RPID

About OPRX OptimizeRx Corporation

OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.

About RPID Rapid Micro Biosystems Inc.

Rapid Micro Biosystems Inc is a life sciences technology company. Its technology uses a sensitive camera and the natural autofluorescence of living cells to identify and quantify microbial growth faster and more accurately than the traditional method, which relies on the human eye. The company develops, manufactures, markets, and sells Growth Direct systems (Systems), proprietary consumables, laboratory information management system (LIMS) connection, and other software and services to address rapid microbial analysis used for quality control in the manufacture of pharmaceuticals, medical devices, and personal care products. Geographically, it generates maximum revenue from the United States, and the rest from Switzerland, Germany, Japan, and all other countries.

Share on Social Networks: